Is Shuttle Pharmaceuticals Inc (SHPH) overvalued? · $1.8M cap
Shuttle Pharmaceuticals Inc (SHPH) is a drug manufacturers - specialty & generic company listed on US.
This page asks whether Shuttle Pharmaceuticals Inc (SHPH) looks expensive on cached numbers — not a short thesis.
No cached income statement for SHPH, so there is no earnings base to call rich or cheap.
SHPH currently screens at market cap $1.8M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SHPH 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SHPH stock page for the full model, not this heading.
Not investment advice.